[Treatment of Lung Cancer Patients 2016-2022: Increased Use of Therapies Including Checkpoint Inhibitors].

Branscheidt S, Klank D, Justenhoven C

Open source

DOI
10.1055/a-2633-6064
Published
2026 Jun
Container
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2633-6064,
  title = {[Treatment of Lung Cancer Patients 2016-2022: Increased Use of Therapies Including Checkpoint Inhibitors].},
  author = {Branscheidt S and Klank D and Justenhoven C},
  year = {2026},
  journal = {Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))},
  doi = {10.1055/a-2633-6064},
  url = {https://doi.org/10.1055/a-2633-6064}
}

RIS

TY  - JOUR
TI  - [Treatment of Lung Cancer Patients 2016-2022: Increased Use of Therapies Including Checkpoint Inhibitors].
AU  - Branscheidt S
AU  - Klank D
AU  - Justenhoven C
PY  - 2026
JO  - Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
DO  - 10.1055/a-2633-6064
UR  - https://doi.org/10.1055/a-2633-6064
ER  - 

APA

S, B., D, K., & C, J. (2026). [Treatment of Lung Cancer Patients 2016-2022: Increased Use of Therapies Including Checkpoint Inhibitors].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). https://doi.org/10.1055/a-2633-6064

Source records